Dietry compliance in coeliac disease.

  • Research type

    Research Study

  • Full title

    An investigation into dietary compliance of patients with coeliac disease

  • IRAS ID

    159160

  • Contact name

    Humayun Muhammad

  • Contact email

    humayun.muhammad@roehampton.ac.uk

  • Sponsor organisation

    Roehampton University

  • Clinicaltrials.gov Identifier

    UNiversity Hospitals of Leicester Ethics Ref No, UHL 11341; Roehampton University Ethics Ref No, LSC 14/ 112

  • Duration of Study in the UK

    0 years, 2 months, 18 days

  • Research summary

    Coeliac disease (CD) is a disorder of the gastrointestinal system where an allergic reaction to gluten (found in wheat and related products) leads the inflammation of the inner lining of the small bowel. This in turns leads to mal-absorption resulting in anaemia, and may lead to skin disorder, cancer and bone disease. Avoiding gluten is the only practical way to counteract this allergic reaction. Patients with coeliac disease are offered strict Gluten free diet (GFD).
    The diet itself is not easy to follow and there are compliance related issues in patients with CD. Compliance is low in Asian patients as shown by one previous study in 2004 (Butterworth et; al) and subsequently in my Pilot Msc project (Muhammad 2012). The MSc project suggested that changes to be made to the design, modify delivery method of the validated questionnaire and a more extensive study should be undertaken which takes into account a larger cohort (1000 this time). In this study clinical data supplemented by clinical letters and laboratory investigation will also be analysed for more objective results.

    We have an extensive cohort of coeliac disease in Leicester and 10 to 15 % of them are Asian. We can now expand our study with slightly different methodology to verify the results or otherwise. This will aid us in helping patients to increase their compliance in future studies by finding out the causes behind the low compliance. This can reduce the burden of active disease. Suppressing disease activity may result in patients’ physical and psychological improvement and economic benefits for the NHS.

  • REC name

    London - Queen Square Research Ethics Committee

  • REC reference

    14/LO/2128

  • Date of REC Opinion

    27 Nov 2014

  • REC opinion

    Favourable Opinion